Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease

Genes and Immunity

Volumn 14, Issue 3, 2013, Pages 170-178

  Xie, C ^a,b   Du, Y ^a   Kumar, K ^a   Li, L ^a   Han, J ^a   Liu, K ^a   Zhou, X J ^c   Mohan, C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

anti GBM; genetics; lupus nephritis; systemic lupus erythematosus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; AZOTEMIA; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; KIDNEY; LUPUS NEPHRITIS; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; MICE, INBRED STRAINS; PROTEINURIA; RABBITS; SPECIES SPECIFICITY;

MUS; ORYCTOLAGUS CUNICULUS;

EID: 84876947931     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.57     Document Type: Article

References (40)

1. Petri M. Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort. Lupus 2005; 14: 970-973. (Pubitemid 43088273)
2. Golbus J, McCune WJ. Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 1994; 20: 213-242. (Pubitemid 24066018)
3. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestation of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337-1344. (Pubitemid 26196894)
4. Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 2012; 27: 3248-3254.
5. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198-1215. (Pubitemid 9053639)
6. Dixon FJ, Andrews BS, Eisenberg RA, McConahey PJ, Theofilopoulos AN, Wilson CB. Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum 1978; 21: S64-S67. (Pubitemid 9127086)
7. Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G et al. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest 1999; 103: 1685-1695. (Pubitemid 29534363)
8. Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 1987; 138: 2883-2889. (Pubitemid 17072763)
9. Liang Z, Xie C, Chen C, Kreska D, Hsu K, Li L et al. Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med 2004; 199: 381-398. (Pubitemid 38252050)
10. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus. Current concepts and continuing controversies. Arthritis Rheum 1996; 39: 894-903. (Pubitemid 26182056)
11. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338: 1359-1368. (Pubitemid 28216666)
12. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189: 1639-1648.
13. Waters ST, McDuffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004; 199: 255-264. (Pubitemid 38129705)
14. Fu Y, Du Y, Mohan C. Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin Immunol 2007; 124: 109-118. (Pubitemid 47059046)
15. Xie C, Zhou XJ, Liu X, Mohan C. Enhanced intrinsic susceptibility to end-organ disease in the lupus prone NZW strain. Arthritis Rheum 2003; 48: 1080-1092. (Pubitemid 36418251)
16. Xie C, Sharma R, Wang W, Zhou XJ, Mohan C. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 2004; 172: 5047-5055. (Pubitemid 38456432)
17. Xie C, Rahman ZS, Xie S, Zhu J, Du Y, Qin X et al. Strain distribution pattern of immune nephritis-A follow-up study. Int Immunol 2008; 20: 719-728. (Pubitemid 351791516)
18. Xie C, Qin X, Jonnala G, Gong Y, Yan M, Zong P et al. Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression. Clin Immunol 2007; 124: 49-56. (Pubitemid 46951035)
19. Xie C, Liu K, Fu Y, Qin X, Jonnala G, Wang T et al. RANTES deficiency attenuates autoantibody-induced glomerulonephritis. J Clin Immunol 2011; 31: 128-135.
20. Fairhurst AM, Xie C, Fu Y, Wang A, Boudreaux C, Zhou XJ et al. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol 2009; 183: 6831-6838.
21. Li L, Mohan C. Genetic basis of murine lupus nephritis. Semin Nephrol 2007; 27: 12-21.
22. Xie C, Mohan C. SLE pathogenesis, Genetic dissection. In: Ganten D, Ruckpaul K (eds) Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine. Springer: New York, 2006, pp 1763-1768.
23. Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sánchez E, Kelly JA et al. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest 2009; 119: 911-923.
24. Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci USA 2001; 98: 1787-1792. (Pubitemid 32165576)
25. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994; 1: 219-229.
26. Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 1979; 22: 1188-1194. (Pubitemid 10163783)
27. Izui S, Iwamoto M, Fossati L, Merino R, Takahashi S, Ibnou-Zekri N. The Yaa gene model of systemic lupus erythematosus. Immunol Rev 1995; 144: 137-156.
28. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312: 1669-1672. (Pubitemid 43902669)
29. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 2006; 103: 9970-9975. (Pubitemid 43993607)
30. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM et al. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007; 27: 801-810. (Pubitemid 350102256)
31. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
32. Hogarth MB, Slingsby JH, Allen PJ, Thompson EM, Chandler P, Davies KA et al. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol 1998; 161: 2753-2761. (Pubitemid 28425694)
33. Haywood ME, Hogarth MB, Slingsby JH, Rose SJ, Allen PJ, Thompson EM et al. Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum 2000; 43: 349-355. (Pubitemid 30395743)
34. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992; 176: 1645-1656.
35. Schaefer L, Tsalastra W, Babelova A, Baliova M, Minnerup J, Sorokin L et al. Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and mammalian target of rapamycin. Am J Pathol 2007; 170: 301-315. (Pubitemid 47339209)
36. Schaefer L. Small leucine-rich proteoglycans in kidney disease. J AM Soc Nephrol 2011; 22: 1200-1207.
37. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-284.
38. Perilo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76: 402-412. (Pubitemid 28218642)
39. Ilarregui JM, Bianco GA, Toscano MA, Rabinovich GA. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis 2005; 64: iv96-103.
40. Tsuchiyama Y, Wada J, Zhang H, Morita Y, Hiragushi K, Hida K et al. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int 2000; 58: 1941-1952.